Headquartered in San Diego, CA and formerly doing business as PEM Technologies, Inc, and Naviscan PET Systems, Naviscan Inc develops and markets compact, high-resolution PET scanners and molecular agents used for high-resolution imaging. These organ-specific molecular imaging scanners provide high-resolution images of abnormal tissue in small body parts. Compact, mobile and easy to use, the Naviscan PEM scanner is a high-resolution PET scanner that produces molecular tomographic images of lesions at 2 mm resolution, allowing physicians to visualize breast tumors about the width of a grain of rice. This enables physicians to precisely characterize abnormal tissue, optimizing surgical planning, monitoring response to therapy, and evaluating suspected recurrence. The firm's PEM Flex⢠PET Scanner has unprecedented 2 mm imaging capability enabling detection of the earliest stages of breast cancer (in situ) and tumors less than 2 millimeters in size with very high accuracy and sensitivity (93%). This cannot be achieved by any other modality, including MRI and is important for early detection. The machine received FDA clearnace in July 200
